The ICD-10 code for Doose Syndrome is G40.4. Doose Syndrome, also known as Myoclonic Astatic Epilepsy (MAE), is a rare form of epilepsy that typically begins in early childhood. It is characterized by generalized tonic-clonic seizures, myoclonic seizures, and atonic seizures. The ICD-9 code for Doose Syndrome is 345.6. It is important to consult with a healthcare professional for accurate diagnosis and appropriate treatment options.
Doose Syndrome, also known as myoclonic-astatic epilepsy, is a rare form of epilepsy that primarily affects children. It is characterized by myoclonic jerks and drop attacks, which are sudden episodes of loss of muscle tone leading to falls. These seizures can be frequent and severe, significantly impacting the quality of life for those affected.
In terms of coding, Doose Syndrome is classified under the International Classification of Diseases, 10th Revision (ICD-10). The specific ICD-10 code for Doose Syndrome is G40.4. This code falls under the broader category of epilepsy and recurrent seizures, which is further classified based on the type of epilepsy and associated features.
On the other hand, the International Classification of Diseases, 9th Revision (ICD-9) was the previous version of the coding system. The corresponding ICD-9 code for Doose Syndrome is 345.4. This code represents generalized nonconvulsive epilepsy, which encompasses various types of epilepsy, including myoclonic-astatic epilepsy (Doose Syndrome).
It is worth noting that accurate coding is essential for medical records, billing, and research purposes. Properly identifying and coding conditions like Doose Syndrome allows healthcare professionals to monitor and manage the condition effectively, while also facilitating accurate data collection for research and healthcare planning.
In conclusion, the ICD-10 code for Doose Syndrome is G40.4, while the corresponding ICD-9 code is 345.4. These codes help classify and document this rare form of epilepsy, enabling healthcare professionals to provide appropriate care and researchers to gain insights into the condition.